Terumo Corporation (TRUMF) 38.4100 $TRUMF Terum
Post# of 273254
Posted On: 09/24/2016 9:08:28 AM
Terumo Corporation (TRUMF) 38.4100 $TRUMF
Terumo Cardiovascular Group and CytoSorbents Announce CytoSorb Cardiac Surgery Partnership
PR Newswire Europe - Mon Sep 12, 6:02AM CDT
Agreement brings innovative anti-inflammatory treatment to cardiac surgery teams in six European countries
CTSO: 6.18 (unch)
Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016-2026 - Research and Markets
PR Newswire Europe - Tue Aug 02, 11:10AM CDT
Research and Markets has announced the addition of the "Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016-2026" [http://www.researchandmarkets.com/research/rjs342/parenteral] report to their offering.
WST: 72.55 (-2.07), UNIS: 2.65 (-0.13)
Neurointerventional Devices Market: Global Industry Analysis to 2025 - Key Players are Medtronic, Penumbra & Terumo Corporation - Research and Markets
BusinessWire - Mon May 09, 4:56AM CDT
Research and Markets has announced the addition of the "Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" report to their offering.
United Kingdom Cardiovascular Surgery Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Terumo Corp, Rocket Medical - Research and Markets
BusinessWire - Mon May 09, 4:38AM CDT
Research and Markets has announced the addition of the "United Kingdom Cardiovascular Surgery Devices Market Outlook to 2021" report to their offering.
MDT: 87.71 (-0.11)
United States Clot Management Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Teleflex Inc, Terumo Corp - Research and Markets
BusinessWire - Fri Apr 22, 11:54AM CDT
Research and Markets has announced the addition of the "United States Clot Management Devices Market Outlook to 2021" report to their offering.
MDT: 87.71 (-0.11), TFX: 171.55 (-5.56)
Infusion Pump Market - Global Forecast to 2020 - Increasing Prevalence of Chronic Diseases a Key Driver
M2 - Mon Jan 18, 5:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/6x6whn/infusion_pump) has announced the addition of the "Infusion Pump Market - Global Forecast to 2020 " report to their offering. The global infusion pump market is poised to reach $10,209.4 Million by 2020 from $7,687.4 Million in 2015, growing at a CAGR of 5.8% during the forecast period. Market growth can be attributed to the increasing prevalence of chronic diseases owing to the rising geriatric population; increasing use of infusion products in home care with favorable reimbursement coverage; and technological improvements in infusion products. However, the presence of stringent regulations for product approval and the occurrence of several cases of medication errors associated with infusion pump (and related product recalls in the recent past) may restrain the growth of the market during the forecast period. Product innovations focusing on improving the safety features of infusion pump are at the center of R&D efforts from leading players in this market. In 2014, North America accounted for the largest share of the infusion pump market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The Asian countries (particularly China and India) and Latin American countries (particularly Brazil) are expected to offer significant growth opportunities for market players in the forecast period. This is majorly attributed to the high patient population & rapidly aging population in these emerging countries, high incidence of chronic disease, rising per capita income in these countries, and improving healthcare infrastructure in these regions. Companies Mentioned: - B. Braun Melsungen Ag - Baxter International Inc - Becton, Dickinson and Company - Fresenius Se & Co. KGAA - Hospira, Inc236 - Johnson & Johnson - Medtronic PLC - Moog Inc. - Roche Diagnostics - Smiths Medical - Terumo Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Infusion Pump Market, By Product 8 Infusion Pump Market, By Application 9 Infusion Pump Market, By End User 10 Global Infusion Pump Market, By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/6x...usion_pump
JNJ: 118.81 (-0.65), MDT: 87.71 (-0.11), MOG.A: 56.80 (-0.37), BAX: 47.49 (-0.71)
Global Diabetes Care Devices Market Analysis Forecasts 2014-2020
M2 - Mon Dec 14, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvltlq/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Analysis - Forecast (2014-2020)" report to their offering. This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This report analyzes the global markets for Diabetes Care Devices. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Market Segments Glucose Monitoring Devices - Blood Glucose Testing Strips - Continuous Glucose Monitoring Devices (CGM) - Blood Glucose Meter - Blood Sampling Devices - Lancets Insulin Delivery Devices - Insulin Pens - Insulin Pumps - Inhaled Insulin - Insulin Injectors - Insulin Syringes Diabetes Control Solutions - Lancets - Hemoglobin A1c Meters - Continuous Blood Glucose Monitoring Devices - Hemoglobin A1c Testing Kits - Test Strips Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Diabetes Care Devices Market by Product 6 Geographical Segmentation 7 Vendor Landscaping 8 Company Profiles - Abbott Laboratories - Becton - Dickinson and Company - Johnson & Johnson - Medtronic Plc - Novo Nordisk A/S - Siemens AG - Tandem Diabetes Care, Inc. - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/wv...l_diabetes
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
Diabetes Care Devices Market - Estimated to Reach USD 2.3 Billion by 2020
M2 - Thu Dec 10, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/hbz53j/diabetes_care) has announced the addition of the "Diabetes Care Devices Market - Forecast to 2020" report to their offering. There are a number of factors contributing to growth in the Diabetes Care Devices Market. Among the most influential are the increasing number of diabetic patients across BRIC countries and the growing research on the diabetes. But the report also lists lifestyle changes as a major factor because it is driving the prevalence of diabetes among the urban population. However, the report does go on to list some of the restraints affecting the market. These include: - High cost of diabetes care devices. - Disparity in reimbursement. - Availability of alternative treatments. - Lack of awareness. China was the leader of the market in 2014 and commanded over half of the market share. There was several contributing factors to the growth in this region, including: - Increasing number of diabetic patients. - Increasing number of international research collaborations. - Government Initiatives. - Expansion of Global Players in the country. However, the report expects China to witness sluggish growth during the forecasted period and projects India to witness the highest growth rate during this time. The key driver in India is the rapid industrialization and urbanization it is experiencing. The BRIC diabetes care devices market is estimated to be valued at USD 1.7 Billion in 2015 and is poised to reach USD 2.3 Billion by 2020, growing at a CAGR of 6.3% during the forecast period. Companies Included - - Abbott Laboratories - Acon Laboratories, Inc. - Arkray, Inc. - Bayer AG - Becton, Dickinson and Company - Dexcom, Inc. - Johnson & Johnson - Medtronic PLC - Novo Nordisk A/S - Roche Diagnostics Limited - Sanofi - Terumo Corporation - Ypsomed AG Report Structure - 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Insights6 Brazil: Diabetes Care Devices Market 7 Russia: Diabetes Care Devices Market 8 India: Diabetes Care Devices Market 9 China: Diabetes Care Devices Market 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hb...betes_care
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
Global Market Study on Neurosurgical Products 2015-2020: Market is Anticipated to Grow to US$7,756.2 Mn by 2022
M2 - Tue Nov 10, 8:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/6q83k8/global_market) has announced the addition of the "Global Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022" report to their offering. The neurosurgical products market is anticipated to grow from an estimated US$3,685.8 Mn by the end of 2015 to US$7,756.2 Mn by 2022at a CAGR of 11.2% during the forecast period. The global neurosurgical products market is witnessing significant growth due to growing geriatric population. Moreover, increasing the incidence of brain tumors, growing government funding, and raising awareness about neurosurgical disorders are also driving the growth of the market. Furthermore, growing demand for minimally invasive surgeries is expected to create growth opportunities for the neurosurgical products market. However, stringent regulatory requirements, long approval times for new neurosurgical products, and availability of alternative treatment for neurosurgical diseases inhibit the growth of the market. North America is projected to be the largest market for neurosurgical products, with an aneurysm being the most prevalent neurosurgical condition, and embolization products being the most preferred neurosurgical product by the end of 2015. Asia Pacific is expected to be the fastest-growing region in terms of revenue while stereotactic radiosurgery is projected to be the fastest-growing neurosurgical product type segment over the forecast period. Aneurysms are abnormal widening or bulging of parts of blood vessels due to weakening of the wall of the blood vessel.The global aneurysms segment is expected to grow from an estimated US$1,328.8 Mn by the end of2015 to US$2,866.1 Mn by 2022 at a CAGR of 11.6% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Condition Chapter 7 Market Size and Forecast by Procedure Chapter 8 Market Size and Forecast by Product Type Chapter 9 Market Size and Forecast by Geography Chapter 10 Competitive Scenario Chapter 11 Company Profiles - B. Braun Melsungen AG - Elekta AB - Integra LifeSciences Holdings Corporation - Johnson & Johnson Services, Inc. - KARL STORZ GmbH & Co. KG. - Medtronic plc - Penumbra, Inc. - Stryker Corporation - Terumo Corporation - Varian Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/6q...bal_market
JNJ: 118.81 (-0.65), VAR: 98.17 (-0.33), MDT: 87.71 (-0.11), PEN: 77.32 (-2.07), SYK: 117.76 (-0.68)
Global Market Study on Home Infusion Therapy Devices: Needleless Connectors to Witness Highest Growth by 2020
M2 - Tue Nov 03, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/5h6prs/global_market) has announced the addition of the "Global Market Study on Home Infusion Therapy Devices: Needleless Connectors to Witness Highest Growth by 2020" report to their offering. The global home infusion therapy devices market is anticipated to grow from US$ 15,905.1 Mn in 2014 to US$ 26,747.8 Mn by 2020 at a CAGR of 9% during the forecast period. Home infusion therapy is used in the treatment of diseases that remain unresponsive to oral medication such as cancer, cancer related pain, and gastrointestinal diseases. It is also used to treat diabetes, dehydration, and cystic fibrosis. Home infusion therapy improves medication adherence and reduces unplanned hospitalization. Some major infusion devices used for the administration of medicines include infusion pump, intravenous set, and needleless connectors. Globally, the home infusion therapy devices market is witnessing significant growth due to the expanding home care market for infusion therapy and increasing applications of infusion devices for relieving pain. Moreover, rising aging population, increasing number of chronic diseases, and technological advancements in infusion devices are also supporting growth of the market. However, increasing risk to patient safety and occurrence of mistakes while using infusion devices, and issues related to reimbursement policies for home infusion therapy inhibit growth of the market. North America is the largest region, while Asia represents the fastest-growing region in the home infusion therapy devices market. Infusion pumps hold largest market share, while needleless connectors represents fastest-growing segment in the market. Volumetric is the largest and fastest-growing infusion pump device in the global home infusion therapy devices market. In terms of application, anti-infectives represent the largest and fastest-growing application in the global home infusion therapy devices market. The home infusion therapy devices market in North America is anticipated to grow from an estimated US$ 6,880.2 Mn in 2014 to US$ 11,666 Mn by 2020 at a CAGR of 9.2% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Market Size and Forecast by Type of Device Chapter 6 Market Size and Forecast of Infusion Pumps by Device Chapter 7 Market Size and Forecast by Application Chapter 8 Market Size and Forecast by Type of Disease Chapter 9 Market Size and Forecast by Region Chapter 10 Competitive Scenario Chapter 11 Company Profiles - B. Braun Melsungen AG - Baxter - Caesarea Medical Electronics - CareFusion Corporation - Fresenius Kabi AG - Hospira, Inc. - ICU Medical, Inc. - JMS Co. Ltd. - Smiths Medical - TERUMO CORPORATION For more information visit http://www.researchandmarkets.com/research/5h...bal_market
ICUI: 126.34 (unch)
Home Infusion Therapy Market Analysis 2015 By Product, By Application And Segment - Forecasts To 2022 for the $31 Billion Industry
M2 - Tue Nov 03, 8:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmmkrk/home_infusion) has announced the addition of the "Home Infusion Therapy Market Analysis By Product, By Application And Segment - Forecasts To 2022" report to their offering. Global home infusion therapy market is expected to reach USD 31.9 billion by 2022 Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings. Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Home Infusion Therapy Industry Outlook Chapter 4. Home Infusion Therapy Product Outlook Chapter 5. Home Infusion Therapy Application Outlook Chapter 6. Home infusion therapy Regional Outlook Chapter 7. Competitive Landscape - Terumo Corporation - B. Braun Melsungen - Caesarea Medical Electronics - Smiths Medical - CareFusion Corporation - ICU Medical Inc. - JMS Co. Ltd. - Baxter Inc. - Fresenius Kabi For more information visit http://www.researchandmarkets.com/research/km...e_infusion
ICUI: 126.34 (unch)
U.S. Markets for Biologic and Tissue Engineered Devices 2015 - Cardiovascular and Neurological Products Analysis
M2 - Tue Oct 27, 9:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fghmqn/u_s_markets_for) has announced the addition of the "U.S. Markets for Biologic and Tissue Engineered Devices - Cardiovascular and Neurological Products" report to their offering. Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and neurological disease represent potential billion dollar markets that could offer a viable therapeutic option for a sizable patient population that has exhausted other therapeutic alternatives. Over 35 novel cellular therapies for cardiovascular and neurological disease are currently in development internationally, and in the United States (U.S.). The scope of the analysis of this report covers companies developing novel cellular therapeutics for the treatment of debilitating and deadly diseases that currently lack adequate therapeutic intervention. Cardiovascular disease-related conditions with cellular therapies in development are discussed in Chapter 2 of this report, which covers acute myocardial infarction, critical limb ischemia, heart failure, and bioengineered vascular grafts. Neurological conditions/diseases discussed in Chapter 3 of this report include Alzheimer's disease, ischemic stroke, Parkinson's disease, and spinal cord injury. Content included in this report includes: - Emerging cellular therapies for cardiovascular and neurological diseases - Companies and biotech firms developing novel cellular therapies - A prospective regulatory approval forecast for cellular therapy products currently in development for cardiovascular and neurological diseases - A speculative market analysis predicting the potential overall market values for cardiovascular and neurological disease stem cell therapies. Key Topics Covered: Executive Summary 1. Tissue Engineering and Cellular Therapy Tools and Techniques 1.1 Biomaterials 1.2 Cell Culture Technology 1.3 Stem Cell Technology 1.4 Immunoisolation Technology 2. Emerging Applications of Tissue Engineering and Cell Transplantation in Cardiovascular Disease Management 2.1 Cellular Therapy and Tissue Engineering 2.2 Cellular Therapy Administration 2.3 Clinical Experience with Stem Cell-Based Myocardial Tissue Repair and Regeneration 2.4 Cellular Therapies for Myocardial Repair and Regeneration in Development 2.5 Emerging Cellular Therapies for Limb Salvage in Critical Limb Ischemia Patients 2.6 Bioengineered Vascular Conduits 2.7 Current and Emerging U.S. Market for Cardiovascular Disease-Related Tissue Engineering and Cellular Therapy Products 3. Emerging Applications of Tissue Engineering and Cell Transplantation in Neurological Disease Management 3.1 Types of Cells Used for Cellular Therapies in Development 3.2 Emerging Stem Cell-Based Therapies for Alzheimer's Disease 3.3 Emerging Stem Cell-Based Therapies for Parkinson's Disease 3.4 Emerging Stem Cell-Based Therapies for Spinal Cord Injury 3.5 Emerging Stem Cell-Based Therapies for Post-Ischemic Stroke 3.6 Potential U.S. Market for Neurological Disease-Related Cellular Therapy Products Appendix: Company Listing Bibliography Companies Mentioned - Athersys - Baxter - Bioheart, Inc. - Biomet Biologics - Bukwang Pharmaceutical - Bundang CHA Hospital - Capricor Therapeutics - Chinese Academy of Military Medical Sciences - Cytori Therapeutics - Ecron Acunova - Fondazione IRCCS Ca'Granda, Ospedale Maggiore Policlinico - Harvest Technologies - Hospital Sao Rafael - Instituto de Medicina Regenerativa/Ageless Regenerative Institute - International Stem Cell Corporation - Medipost - Mesoblast Ltd. - NeoStem - Neuralstem - Neurogen Brain and Spine Insitute - Osiris Therapeutics - Pharmicell - Pluristem Therapeutics - ReNeuron, Ltd. - SanBio - StemCells, Inc. - Stemedica - Stempeutics - Taxus Cardium Pharmaceuticals Group - Terumo Corporation - The General Hospital of Chinese Armed Police Forces - Translational Biosciences - University of Irvine - Vericel For more information visit http://www.researchandmarkets.com/research/fg...arkets_for
CAPR: 3.51 (-0.12), PSTI: 1.63 (+0.01), CYTX: 2.12 (+0.03), OSIR: 4.78 (-0.11)
Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product - Global Forecast to 2020
M2 - Tue Oct 27, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/db69wx/neurovascular) has announced the addition of the "Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product - Global Forecast to 2020 " report to their offering. The global neurovascular devices/interventional neurology market is poised to reach -$2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020 North America is expected to hold the largest share of 47.3% of the global market in 2015. Market growth is being propelled by growing target patient population, technological advancements in the field of interventional neurosurgeries, favorable medical reimbursement scenario across mature markets, and expanding healthcare infrastructure in developing countries. However, factors such as ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market. In addition, stringent regulatory policies (that regulate product development and commercialization) across major markets are posing significant challenges for the growth of the neurovascular devices/interventional neurology market during the forecast period. In this report, the global neurovascular devices/interventional neurology market is segmented on the basis of technology (embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy) and product (cerebral balloon angioplasty & stenting systems, aneurysm coiling & embolization devices, support devices, and neurothrombectomy devices). The aneurysm coiling and embolization devices segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by cerebral balloon angioplasty & stenting systems. The cerebral balloon angioplasty & stenting systems segment is expected to grow at the highest CAGR during the next five years owing to factors such as an increasing number of researches, rising public-private funding to develop novel carotid stents & occlusion catheter products, and growing availability of technologically advanced stents & embolic protection devices across major markets (such as Europe, Japan, and the U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Neurovascular Devices/Interventional Neurology Market 7 Neurovascular Devices/Interventional Neurology Market 8 Neurovascular Devices/Interventional Neurology Market 9 Competitive Landscape 10 Company Profiles - Abbott Laboratories - Geographic Mix - Johnson & Johnson - Medikit Co., Ltd. - Medtronic Plc - Merit Medical Systems, Inc. - Microport Scientific Corporation - Penumbra, Inc. - Strategic Benchmarking - Stryker Corporation - Terumo Corporation - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/db...rovascular
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), MDT: 87.71 (-0.11), PEN: 77.32 (-2.07), MMSI: 23.96 (-0.32), SYK: 117.76 (-0.68)
Vascular and Non-Vascular Stents: Global Market 2015 - Forecast to 2021
M2 - Mon Oct 19, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cc3t5b/vascular_and) has announced the addition of the "Vascular and Non-Vascular Stents Global Market - Forecast to 2021" report to their offering. Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents. By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents. Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Stents Market, By Types 5 Stents Market, By Application 6 Stents Market, By Materials 7 Stents Market, By Coatings 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Abbott Laboratories - B. Braun Melsungen Ag - Biosensors International Group - Biotronik Se & Co. Kg - Boston Scientific Corpoartion - C.R.Bard Inc. - Cook Medical Inc - Johnson & Johnson (Cordis Corporation) - Medtronic Inc - Microport Scientific Corporation - Olympus Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/cc...scular_and
BSX: 23.71 (-0.02), JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), MDT: 87.71 (-0.11)
Global Diabetes Care Devices Market Outlook 2015-2020 - Market is Expected to Grow at a CAGR of 5.2%
M2 - Wed Oct 07, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jb8dxs/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Outlook: 2015-2020" report to their offering. The global diabetes care devices market is expected to grow at a CAGR of 5.2% from 2015 to 2020 to reach $24.6 billion by 2020 This market is mainly driven by increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped and emerging markets, and rising awareness among people about diabetes care are also accelerating the growth of this market. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, lack of awareness, strict regulatory obligations, and high cost of diabetic food hinders the growth of this market to some extent. The research report on the diabetes care devices market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product segments such as diabetes control solutions, diabetes monitoring devices, and insulin delivery devices. The diabetes monitoring devices segment further sub-segmented into continuous blood glucose monitoring devices, test strips, lancets, and hemoglobin A1c (HbA1c) testing kits. The insulin delivery devices further sub-segmented into insulin syringes, insulin pens, insulin pumps, and insulin injectors. Key Topics Covered: 1 Introduction to Diabetes Care Devices Market 2 Executive Summary 3 Market Insights 4 Global Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Product Type 5 Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Geography 6 Global Diabetes Care Devices Market- Competitive Landscape 7 Company Profiles - ARKRAY Inc. - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Dexcom, Inc. - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Johnson & Johnson - Medtronic, Inc. - Novo Nordisk A/S - Sanofi S.A - Tandem Diabetes Care, Inc - Terumo Corporation - Ypsomed AG For more information visit http://www.researchandmarkets.com/research/jb...l_diabetes
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11), LLY: 81.16 (-0.13)
Injectable Drug Delivery Market: By Devices, Therapeutics & Formulations 2015 - 2020
M2 - Wed Sep 30, 8:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ltfg29/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market:By Devices, Therapeutics & Formulations (2015 - 2020)" report to their offering. The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 - 2018. The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report. While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 - 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years. Analyzing the competitive landscape of the global conventional injectable devices market for 2012 the report puts forward the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%. Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Global Injectable Drug Delivery - Market Forces 5. Global Injectable Drug Delivery Market - Strategic Analysis 6. Global Injectable Drug Delivery Market - By Type 7. Global Injectable Drug Delivery Market - By Type of Diseases 8. Global Injectable Drug Delivery Market - Geographic Analysis 9. Market Entropy 10. Company Profiles 11. Appendix Companies Mentioned - Becton Dickinson and Company (BD) - Baxter International Inc. - Consort Medical PLC - Crossject SA - Eli Lilly and Company - Elcam Medical - Novo Nordisk - Owen Mumford Ltd - Sanofi - Schott AG - Terumo Corporation - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lt...table_drug
BDX: 179.50 (-2.05), NVO: 44.88 (-0.69), BAX: 47.49 (-0.71), LLY: 81.16 (-0.13)
The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020
PR Newswire Europe - Thu Sep 03, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pqvrgz/diabetes_care [http://www.researchandmarkets.com/research/pqvrgz/diabetes_care]) has announced the addition of the "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020" [http://www.researchandmarkets.com/research/pqvrgz/diabetes_care] report to their offering.
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
BRIC Diabetes Care Devices Market Report 2015-2020
M2 - Thu Sep 03, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ntshf7/diabetes_care) has announced the addition of the "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020" report to their offering. The BRIC diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market. China accounted for the largest share of the BRIC diabetes care devices market; it accounted for a market share of 55.5% in 2014. Major factors driving the growth of this market in China are the rising diabetic population, increasing international collaborations, and presence of large number of diabetes care device manufacturers in the country. The Indian market, on the other hand, is expected to witness the highest CAGR, mainly due to the growing diabetic population, rapid urbanization and industrialization, and growing research on diabetes and its management. Some of the major players operating in the BRIC diabetes care devices market are Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France). For more information visit http://www.researchandmarkets.com/research/nt...betes_care
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
PTCA Balloons Pipeline Review, 2015 - Extensive Coverage of the PTCA Balloon Products Under Development
M2 - Mon Aug 17, 2:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pgbb35/ptca_balloons) has announced the addition of the "PTCA Balloons - Pipeline Review, 2015" report to their offering. PTCA Balloons - Pipeline Review, 2015 Summary Our Medical Devices sector report, PTCA Balloons - Pipeline Review, 2015" provides an overview of PTCA Balloon products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key PTCA Balloon pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of PTCA Balloon products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 PTCA Balloons - Pipeline Products under Development by Companies 5 PTCA Balloons Companies and Product Overview 6 PTCA Balloons- Recent Developments 7 Appendix Companies Mentioned - Acrostak (Schweiz) AG - Andramed GmbH - CID S.r.l. - Innovia LLC - Meril Life Sciences Pvt. Ltd. - MicroPort Scientific Corporation - Pressure Products, Inc. - Terumo Corporation - VasoTech Inc. For more information visit http://www.researchandmarkets.com/research/pg...a_balloons
Terumo Cardiovascular Group and CytoSorbents Announce CytoSorb Cardiac Surgery Partnership
PR Newswire Europe - Mon Sep 12, 6:02AM CDT
Agreement brings innovative anti-inflammatory treatment to cardiac surgery teams in six European countries
CTSO: 6.18 (unch)
Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016-2026 - Research and Markets
PR Newswire Europe - Tue Aug 02, 11:10AM CDT
Research and Markets has announced the addition of the "Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016-2026" [http://www.researchandmarkets.com/research/rjs342/parenteral] report to their offering.
WST: 72.55 (-2.07), UNIS: 2.65 (-0.13)
Neurointerventional Devices Market: Global Industry Analysis to 2025 - Key Players are Medtronic, Penumbra & Terumo Corporation - Research and Markets
BusinessWire - Mon May 09, 4:56AM CDT
Research and Markets has announced the addition of the "Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" report to their offering.
United Kingdom Cardiovascular Surgery Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Terumo Corp, Rocket Medical - Research and Markets
BusinessWire - Mon May 09, 4:38AM CDT
Research and Markets has announced the addition of the "United Kingdom Cardiovascular Surgery Devices Market Outlook to 2021" report to their offering.
MDT: 87.71 (-0.11)
United States Clot Management Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Teleflex Inc, Terumo Corp - Research and Markets
BusinessWire - Fri Apr 22, 11:54AM CDT
Research and Markets has announced the addition of the "United States Clot Management Devices Market Outlook to 2021" report to their offering.
MDT: 87.71 (-0.11), TFX: 171.55 (-5.56)
Infusion Pump Market - Global Forecast to 2020 - Increasing Prevalence of Chronic Diseases a Key Driver
M2 - Mon Jan 18, 5:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/6x6whn/infusion_pump) has announced the addition of the "Infusion Pump Market - Global Forecast to 2020 " report to their offering. The global infusion pump market is poised to reach $10,209.4 Million by 2020 from $7,687.4 Million in 2015, growing at a CAGR of 5.8% during the forecast period. Market growth can be attributed to the increasing prevalence of chronic diseases owing to the rising geriatric population; increasing use of infusion products in home care with favorable reimbursement coverage; and technological improvements in infusion products. However, the presence of stringent regulations for product approval and the occurrence of several cases of medication errors associated with infusion pump (and related product recalls in the recent past) may restrain the growth of the market during the forecast period. Product innovations focusing on improving the safety features of infusion pump are at the center of R&D efforts from leading players in this market. In 2014, North America accounted for the largest share of the infusion pump market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The Asian countries (particularly China and India) and Latin American countries (particularly Brazil) are expected to offer significant growth opportunities for market players in the forecast period. This is majorly attributed to the high patient population & rapidly aging population in these emerging countries, high incidence of chronic disease, rising per capita income in these countries, and improving healthcare infrastructure in these regions. Companies Mentioned: - B. Braun Melsungen Ag - Baxter International Inc - Becton, Dickinson and Company - Fresenius Se & Co. KGAA - Hospira, Inc236 - Johnson & Johnson - Medtronic PLC - Moog Inc. - Roche Diagnostics - Smiths Medical - Terumo Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Infusion Pump Market, By Product 8 Infusion Pump Market, By Application 9 Infusion Pump Market, By End User 10 Global Infusion Pump Market, By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/6x...usion_pump
JNJ: 118.81 (-0.65), MDT: 87.71 (-0.11), MOG.A: 56.80 (-0.37), BAX: 47.49 (-0.71)
Global Diabetes Care Devices Market Analysis Forecasts 2014-2020
M2 - Mon Dec 14, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvltlq/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Analysis - Forecast (2014-2020)" report to their offering. This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This report analyzes the global markets for Diabetes Care Devices. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Market Segments Glucose Monitoring Devices - Blood Glucose Testing Strips - Continuous Glucose Monitoring Devices (CGM) - Blood Glucose Meter - Blood Sampling Devices - Lancets Insulin Delivery Devices - Insulin Pens - Insulin Pumps - Inhaled Insulin - Insulin Injectors - Insulin Syringes Diabetes Control Solutions - Lancets - Hemoglobin A1c Meters - Continuous Blood Glucose Monitoring Devices - Hemoglobin A1c Testing Kits - Test Strips Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Diabetes Care Devices Market by Product 6 Geographical Segmentation 7 Vendor Landscaping 8 Company Profiles - Abbott Laboratories - Becton - Dickinson and Company - Johnson & Johnson - Medtronic Plc - Novo Nordisk A/S - Siemens AG - Tandem Diabetes Care, Inc. - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/wv...l_diabetes
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
Diabetes Care Devices Market - Estimated to Reach USD 2.3 Billion by 2020
M2 - Thu Dec 10, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/hbz53j/diabetes_care) has announced the addition of the "Diabetes Care Devices Market - Forecast to 2020" report to their offering. There are a number of factors contributing to growth in the Diabetes Care Devices Market. Among the most influential are the increasing number of diabetic patients across BRIC countries and the growing research on the diabetes. But the report also lists lifestyle changes as a major factor because it is driving the prevalence of diabetes among the urban population. However, the report does go on to list some of the restraints affecting the market. These include: - High cost of diabetes care devices. - Disparity in reimbursement. - Availability of alternative treatments. - Lack of awareness. China was the leader of the market in 2014 and commanded over half of the market share. There was several contributing factors to the growth in this region, including: - Increasing number of diabetic patients. - Increasing number of international research collaborations. - Government Initiatives. - Expansion of Global Players in the country. However, the report expects China to witness sluggish growth during the forecasted period and projects India to witness the highest growth rate during this time. The key driver in India is the rapid industrialization and urbanization it is experiencing. The BRIC diabetes care devices market is estimated to be valued at USD 1.7 Billion in 2015 and is poised to reach USD 2.3 Billion by 2020, growing at a CAGR of 6.3% during the forecast period. Companies Included - - Abbott Laboratories - Acon Laboratories, Inc. - Arkray, Inc. - Bayer AG - Becton, Dickinson and Company - Dexcom, Inc. - Johnson & Johnson - Medtronic PLC - Novo Nordisk A/S - Roche Diagnostics Limited - Sanofi - Terumo Corporation - Ypsomed AG Report Structure - 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Insights6 Brazil: Diabetes Care Devices Market 7 Russia: Diabetes Care Devices Market 8 India: Diabetes Care Devices Market 9 China: Diabetes Care Devices Market 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/hb...betes_care
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
Global Market Study on Neurosurgical Products 2015-2020: Market is Anticipated to Grow to US$7,756.2 Mn by 2022
M2 - Tue Nov 10, 8:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/6q83k8/global_market) has announced the addition of the "Global Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022" report to their offering. The neurosurgical products market is anticipated to grow from an estimated US$3,685.8 Mn by the end of 2015 to US$7,756.2 Mn by 2022at a CAGR of 11.2% during the forecast period. The global neurosurgical products market is witnessing significant growth due to growing geriatric population. Moreover, increasing the incidence of brain tumors, growing government funding, and raising awareness about neurosurgical disorders are also driving the growth of the market. Furthermore, growing demand for minimally invasive surgeries is expected to create growth opportunities for the neurosurgical products market. However, stringent regulatory requirements, long approval times for new neurosurgical products, and availability of alternative treatment for neurosurgical diseases inhibit the growth of the market. North America is projected to be the largest market for neurosurgical products, with an aneurysm being the most prevalent neurosurgical condition, and embolization products being the most preferred neurosurgical product by the end of 2015. Asia Pacific is expected to be the fastest-growing region in terms of revenue while stereotactic radiosurgery is projected to be the fastest-growing neurosurgical product type segment over the forecast period. Aneurysms are abnormal widening or bulging of parts of blood vessels due to weakening of the wall of the blood vessel.The global aneurysms segment is expected to grow from an estimated US$1,328.8 Mn by the end of2015 to US$2,866.1 Mn by 2022 at a CAGR of 11.6% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Condition Chapter 7 Market Size and Forecast by Procedure Chapter 8 Market Size and Forecast by Product Type Chapter 9 Market Size and Forecast by Geography Chapter 10 Competitive Scenario Chapter 11 Company Profiles - B. Braun Melsungen AG - Elekta AB - Integra LifeSciences Holdings Corporation - Johnson & Johnson Services, Inc. - KARL STORZ GmbH & Co. KG. - Medtronic plc - Penumbra, Inc. - Stryker Corporation - Terumo Corporation - Varian Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/6q...bal_market
JNJ: 118.81 (-0.65), VAR: 98.17 (-0.33), MDT: 87.71 (-0.11), PEN: 77.32 (-2.07), SYK: 117.76 (-0.68)
Global Market Study on Home Infusion Therapy Devices: Needleless Connectors to Witness Highest Growth by 2020
M2 - Tue Nov 03, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/5h6prs/global_market) has announced the addition of the "Global Market Study on Home Infusion Therapy Devices: Needleless Connectors to Witness Highest Growth by 2020" report to their offering. The global home infusion therapy devices market is anticipated to grow from US$ 15,905.1 Mn in 2014 to US$ 26,747.8 Mn by 2020 at a CAGR of 9% during the forecast period. Home infusion therapy is used in the treatment of diseases that remain unresponsive to oral medication such as cancer, cancer related pain, and gastrointestinal diseases. It is also used to treat diabetes, dehydration, and cystic fibrosis. Home infusion therapy improves medication adherence and reduces unplanned hospitalization. Some major infusion devices used for the administration of medicines include infusion pump, intravenous set, and needleless connectors. Globally, the home infusion therapy devices market is witnessing significant growth due to the expanding home care market for infusion therapy and increasing applications of infusion devices for relieving pain. Moreover, rising aging population, increasing number of chronic diseases, and technological advancements in infusion devices are also supporting growth of the market. However, increasing risk to patient safety and occurrence of mistakes while using infusion devices, and issues related to reimbursement policies for home infusion therapy inhibit growth of the market. North America is the largest region, while Asia represents the fastest-growing region in the home infusion therapy devices market. Infusion pumps hold largest market share, while needleless connectors represents fastest-growing segment in the market. Volumetric is the largest and fastest-growing infusion pump device in the global home infusion therapy devices market. In terms of application, anti-infectives represent the largest and fastest-growing application in the global home infusion therapy devices market. The home infusion therapy devices market in North America is anticipated to grow from an estimated US$ 6,880.2 Mn in 2014 to US$ 11,666 Mn by 2020 at a CAGR of 9.2% during the forecast period. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Market Size and Forecast by Type of Device Chapter 6 Market Size and Forecast of Infusion Pumps by Device Chapter 7 Market Size and Forecast by Application Chapter 8 Market Size and Forecast by Type of Disease Chapter 9 Market Size and Forecast by Region Chapter 10 Competitive Scenario Chapter 11 Company Profiles - B. Braun Melsungen AG - Baxter - Caesarea Medical Electronics - CareFusion Corporation - Fresenius Kabi AG - Hospira, Inc. - ICU Medical, Inc. - JMS Co. Ltd. - Smiths Medical - TERUMO CORPORATION For more information visit http://www.researchandmarkets.com/research/5h...bal_market
ICUI: 126.34 (unch)
Home Infusion Therapy Market Analysis 2015 By Product, By Application And Segment - Forecasts To 2022 for the $31 Billion Industry
M2 - Tue Nov 03, 8:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/kmmkrk/home_infusion) has announced the addition of the "Home Infusion Therapy Market Analysis By Product, By Application And Segment - Forecasts To 2022" report to their offering. Global home infusion therapy market is expected to reach USD 31.9 billion by 2022 Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings. Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Home Infusion Therapy Industry Outlook Chapter 4. Home Infusion Therapy Product Outlook Chapter 5. Home Infusion Therapy Application Outlook Chapter 6. Home infusion therapy Regional Outlook Chapter 7. Competitive Landscape - Terumo Corporation - B. Braun Melsungen - Caesarea Medical Electronics - Smiths Medical - CareFusion Corporation - ICU Medical Inc. - JMS Co. Ltd. - Baxter Inc. - Fresenius Kabi For more information visit http://www.researchandmarkets.com/research/km...e_infusion
ICUI: 126.34 (unch)
U.S. Markets for Biologic and Tissue Engineered Devices 2015 - Cardiovascular and Neurological Products Analysis
M2 - Tue Oct 27, 9:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fghmqn/u_s_markets_for) has announced the addition of the "U.S. Markets for Biologic and Tissue Engineered Devices - Cardiovascular and Neurological Products" report to their offering. Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and neurological disease represent potential billion dollar markets that could offer a viable therapeutic option for a sizable patient population that has exhausted other therapeutic alternatives. Over 35 novel cellular therapies for cardiovascular and neurological disease are currently in development internationally, and in the United States (U.S.). The scope of the analysis of this report covers companies developing novel cellular therapeutics for the treatment of debilitating and deadly diseases that currently lack adequate therapeutic intervention. Cardiovascular disease-related conditions with cellular therapies in development are discussed in Chapter 2 of this report, which covers acute myocardial infarction, critical limb ischemia, heart failure, and bioengineered vascular grafts. Neurological conditions/diseases discussed in Chapter 3 of this report include Alzheimer's disease, ischemic stroke, Parkinson's disease, and spinal cord injury. Content included in this report includes: - Emerging cellular therapies for cardiovascular and neurological diseases - Companies and biotech firms developing novel cellular therapies - A prospective regulatory approval forecast for cellular therapy products currently in development for cardiovascular and neurological diseases - A speculative market analysis predicting the potential overall market values for cardiovascular and neurological disease stem cell therapies. Key Topics Covered: Executive Summary 1. Tissue Engineering and Cellular Therapy Tools and Techniques 1.1 Biomaterials 1.2 Cell Culture Technology 1.3 Stem Cell Technology 1.4 Immunoisolation Technology 2. Emerging Applications of Tissue Engineering and Cell Transplantation in Cardiovascular Disease Management 2.1 Cellular Therapy and Tissue Engineering 2.2 Cellular Therapy Administration 2.3 Clinical Experience with Stem Cell-Based Myocardial Tissue Repair and Regeneration 2.4 Cellular Therapies for Myocardial Repair and Regeneration in Development 2.5 Emerging Cellular Therapies for Limb Salvage in Critical Limb Ischemia Patients 2.6 Bioengineered Vascular Conduits 2.7 Current and Emerging U.S. Market for Cardiovascular Disease-Related Tissue Engineering and Cellular Therapy Products 3. Emerging Applications of Tissue Engineering and Cell Transplantation in Neurological Disease Management 3.1 Types of Cells Used for Cellular Therapies in Development 3.2 Emerging Stem Cell-Based Therapies for Alzheimer's Disease 3.3 Emerging Stem Cell-Based Therapies for Parkinson's Disease 3.4 Emerging Stem Cell-Based Therapies for Spinal Cord Injury 3.5 Emerging Stem Cell-Based Therapies for Post-Ischemic Stroke 3.6 Potential U.S. Market for Neurological Disease-Related Cellular Therapy Products Appendix: Company Listing Bibliography Companies Mentioned - Athersys - Baxter - Bioheart, Inc. - Biomet Biologics - Bukwang Pharmaceutical - Bundang CHA Hospital - Capricor Therapeutics - Chinese Academy of Military Medical Sciences - Cytori Therapeutics - Ecron Acunova - Fondazione IRCCS Ca'Granda, Ospedale Maggiore Policlinico - Harvest Technologies - Hospital Sao Rafael - Instituto de Medicina Regenerativa/Ageless Regenerative Institute - International Stem Cell Corporation - Medipost - Mesoblast Ltd. - NeoStem - Neuralstem - Neurogen Brain and Spine Insitute - Osiris Therapeutics - Pharmicell - Pluristem Therapeutics - ReNeuron, Ltd. - SanBio - StemCells, Inc. - Stemedica - Stempeutics - Taxus Cardium Pharmaceuticals Group - Terumo Corporation - The General Hospital of Chinese Armed Police Forces - Translational Biosciences - University of Irvine - Vericel For more information visit http://www.researchandmarkets.com/research/fg...arkets_for
CAPR: 3.51 (-0.12), PSTI: 1.63 (+0.01), CYTX: 2.12 (+0.03), OSIR: 4.78 (-0.11)
Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product - Global Forecast to 2020
M2 - Tue Oct 27, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/db69wx/neurovascular) has announced the addition of the "Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product - Global Forecast to 2020 " report to their offering. The global neurovascular devices/interventional neurology market is poised to reach -$2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020 North America is expected to hold the largest share of 47.3% of the global market in 2015. Market growth is being propelled by growing target patient population, technological advancements in the field of interventional neurosurgeries, favorable medical reimbursement scenario across mature markets, and expanding healthcare infrastructure in developing countries. However, factors such as ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market. In addition, stringent regulatory policies (that regulate product development and commercialization) across major markets are posing significant challenges for the growth of the neurovascular devices/interventional neurology market during the forecast period. In this report, the global neurovascular devices/interventional neurology market is segmented on the basis of technology (embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy) and product (cerebral balloon angioplasty & stenting systems, aneurysm coiling & embolization devices, support devices, and neurothrombectomy devices). The aneurysm coiling and embolization devices segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by cerebral balloon angioplasty & stenting systems. The cerebral balloon angioplasty & stenting systems segment is expected to grow at the highest CAGR during the next five years owing to factors such as an increasing number of researches, rising public-private funding to develop novel carotid stents & occlusion catheter products, and growing availability of technologically advanced stents & embolic protection devices across major markets (such as Europe, Japan, and the U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Neurovascular Devices/Interventional Neurology Market 7 Neurovascular Devices/Interventional Neurology Market 8 Neurovascular Devices/Interventional Neurology Market 9 Competitive Landscape 10 Company Profiles - Abbott Laboratories - Geographic Mix - Johnson & Johnson - Medikit Co., Ltd. - Medtronic Plc - Merit Medical Systems, Inc. - Microport Scientific Corporation - Penumbra, Inc. - Strategic Benchmarking - Stryker Corporation - Terumo Corporation - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/db...rovascular
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), MDT: 87.71 (-0.11), PEN: 77.32 (-2.07), MMSI: 23.96 (-0.32), SYK: 117.76 (-0.68)
Vascular and Non-Vascular Stents: Global Market 2015 - Forecast to 2021
M2 - Mon Oct 19, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cc3t5b/vascular_and) has announced the addition of the "Vascular and Non-Vascular Stents Global Market - Forecast to 2021" report to their offering. Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents. By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents. Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Stents Market, By Types 5 Stents Market, By Application 6 Stents Market, By Materials 7 Stents Market, By Coatings 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Abbott Laboratories - B. Braun Melsungen Ag - Biosensors International Group - Biotronik Se & Co. Kg - Boston Scientific Corpoartion - C.R.Bard Inc. - Cook Medical Inc - Johnson & Johnson (Cordis Corporation) - Medtronic Inc - Microport Scientific Corporation - Olympus Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/cc...scular_and
BSX: 23.71 (-0.02), JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), MDT: 87.71 (-0.11)
Global Diabetes Care Devices Market Outlook 2015-2020 - Market is Expected to Grow at a CAGR of 5.2%
M2 - Wed Oct 07, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jb8dxs/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Outlook: 2015-2020" report to their offering. The global diabetes care devices market is expected to grow at a CAGR of 5.2% from 2015 to 2020 to reach $24.6 billion by 2020 This market is mainly driven by increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped and emerging markets, and rising awareness among people about diabetes care are also accelerating the growth of this market. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, lack of awareness, strict regulatory obligations, and high cost of diabetic food hinders the growth of this market to some extent. The research report on the diabetes care devices market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product segments such as diabetes control solutions, diabetes monitoring devices, and insulin delivery devices. The diabetes monitoring devices segment further sub-segmented into continuous blood glucose monitoring devices, test strips, lancets, and hemoglobin A1c (HbA1c) testing kits. The insulin delivery devices further sub-segmented into insulin syringes, insulin pens, insulin pumps, and insulin injectors. Key Topics Covered: 1 Introduction to Diabetes Care Devices Market 2 Executive Summary 3 Market Insights 4 Global Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Product Type 5 Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Geography 6 Global Diabetes Care Devices Market- Competitive Landscape 7 Company Profiles - ARKRAY Inc. - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Dexcom, Inc. - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Johnson & Johnson - Medtronic, Inc. - Novo Nordisk A/S - Sanofi S.A - Tandem Diabetes Care, Inc - Terumo Corporation - Ypsomed AG For more information visit http://www.researchandmarkets.com/research/jb...l_diabetes
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11), LLY: 81.16 (-0.13)
Injectable Drug Delivery Market: By Devices, Therapeutics & Formulations 2015 - 2020
M2 - Wed Sep 30, 8:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ltfg29/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market:By Devices, Therapeutics & Formulations (2015 - 2020)" report to their offering. The global injectable drug delivery devices market is expected to increase from around $ 11.6 bn in 2013 to around $ 17.5 bn in 2018. Self-injection devices are expected to grow at the highest growth rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period 2013 - 2018. The Global Injectable Drug Delivery Devices Market has been analyzed with respect to the demand for devices from different countries across the globe. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2020. The drug injection devices market has been segmented into conventional injectors and self-injection devices broadly. Similarly the drug formulations market has been segmented into the conventional drugs and novel drugs segments. The therapeutic areas are further segmented and analyzed in this report. While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to grow at 16.6% during 2013 - 2018. Conventional injection devices hold around 87% market share currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices increases in the next 5 years. Analyzing the competitive landscape of the global conventional injectable devices market for 2012 the report puts forward the opinion that Becton Dickinson & Co. had the top position with a market share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two companies along with Terumo Corporation and Schott AG together held market share of around 85%. Key Topics Covered: 1. Market Overview 2. Executive Summary 3. Market Landscape 4. Global Injectable Drug Delivery - Market Forces 5. Global Injectable Drug Delivery Market - Strategic Analysis 6. Global Injectable Drug Delivery Market - By Type 7. Global Injectable Drug Delivery Market - By Type of Diseases 8. Global Injectable Drug Delivery Market - Geographic Analysis 9. Market Entropy 10. Company Profiles 11. Appendix Companies Mentioned - Becton Dickinson and Company (BD) - Baxter International Inc. - Consort Medical PLC - Crossject SA - Eli Lilly and Company - Elcam Medical - Novo Nordisk - Owen Mumford Ltd - Sanofi - Schott AG - Terumo Corporation - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lt...table_drug
BDX: 179.50 (-2.05), NVO: 44.88 (-0.69), BAX: 47.49 (-0.71), LLY: 81.16 (-0.13)
The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020
PR Newswire Europe - Thu Sep 03, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pqvrgz/diabetes_care [http://www.researchandmarkets.com/research/pqvrgz/diabetes_care]) has announced the addition of the "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020" [http://www.researchandmarkets.com/research/pqvrgz/diabetes_care] report to their offering.
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
BRIC Diabetes Care Devices Market Report 2015-2020
M2 - Thu Sep 03, 5:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ntshf7/diabetes_care) has announced the addition of the "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020" report to their offering. The BRIC diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market. China accounted for the largest share of the BRIC diabetes care devices market; it accounted for a market share of 55.5% in 2014. Major factors driving the growth of this market in China are the rising diabetic population, increasing international collaborations, and presence of large number of diabetes care device manufacturers in the country. The Indian market, on the other hand, is expected to witness the highest CAGR, mainly due to the growing diabetic population, rapid urbanization and industrialization, and growing research on diabetes and its management. Some of the major players operating in the BRIC diabetes care devices market are Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France). For more information visit http://www.researchandmarkets.com/research/nt...betes_care
JNJ: 118.81 (-0.65), ABT: 42.19 (-0.03), NVO: 44.88 (-0.69), MDT: 87.71 (-0.11)
PTCA Balloons Pipeline Review, 2015 - Extensive Coverage of the PTCA Balloon Products Under Development
M2 - Mon Aug 17, 2:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pgbb35/ptca_balloons) has announced the addition of the "PTCA Balloons - Pipeline Review, 2015" report to their offering. PTCA Balloons - Pipeline Review, 2015 Summary Our Medical Devices sector report, PTCA Balloons - Pipeline Review, 2015" provides an overview of PTCA Balloon products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key PTCA Balloon pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of PTCA Balloon products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 PTCA Balloons - Pipeline Products under Development by Companies 5 PTCA Balloons Companies and Product Overview 6 PTCA Balloons- Recent Developments 7 Appendix Companies Mentioned - Acrostak (Schweiz) AG - Andramed GmbH - CID S.r.l. - Innovia LLC - Meril Life Sciences Pvt. Ltd. - MicroPort Scientific Corporation - Pressure Products, Inc. - Terumo Corporation - VasoTech Inc. For more information visit http://www.researchandmarkets.com/research/pg...a_balloons
(0)
(0)Scroll down for more posts ▼